Yu Yamaguchi

Dr. Yu Yamaguchi


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HYHayato Yamamoto
Hayato Yamamoto
YTYuki Tobisawa
Yuki Tobisawa
TIToshihiro Inubushi
Toshihiro Inubushi
FIFumitoshi Irie
Fumitoshi Irie
COChikara Ohyama
Chikara Ohyama
YYYu Yamaguchi
Yu Yamaguchi
Hyaluronan (HA) is an extremely large polysaccharide (glycosaminoglycan) involved in many cellular functions. HA catabolism is thought to involve the initial cleavage of extracellular high-molecular-weight (HMW) HA into intermediate-size HA by an extracellular or cell-surface hyaluronidase, internalization of intermediate-size HA, and complete degradation into monosaccharides in lysosomes. Despite considerable research, the identity of the hyaluronidase responsible for the initial HA cleavage in the extracellular space remains elusive. HYAL1 and HYAL2 have properties more consistent with lysosomal hyaluronidases, whereas CEMIP/KIAA1199, a recently identified HA-binding molecule that has HA-degrading activity, requires the participation of the clathrin-coated pit pathway of live cells for HA degradation. Here we show that transmembrane protein 2 (TMEM2), a mammalian homolog of a protein playing a role in zebrafish endocardial cushion development, is a cell-surface hyaluronidase. Live immunostaining and surface biotinylation assays confirmed that mouse TMEM2 is expressed on the cell surface in a type II transmembrane topology. TMEM2 degraded HMW-HA into ∼5-kDa fragments but did not cleave chondroitin sulfate or dermatan sulfate, indicating its specificity to HA. The hyaluronidase activity of TMEM2 was Ca2+-dependent; the enzyme's pH optimum is around 6–7, and unlike CEMIP/KIAA1199, TMEM2 does not require the participation of live cells for its hyaluronidase activity. Moreover, TMEM2-expressing cells could eliminate HA immobilized on a glass surface in a contact-dependent manner. Together, these data suggest that TMEM2 is the long-sought-after hyaluronidase that cleaves extracellular HMW-HA into intermediate-size fragments before internalization and degradation in the lysosome.

1 May 2019 in Matrix Biology
Verified
Journal Article
Closed access
YYYu Yamaguchi
Yu Yamaguchi
HYHayato Yamamoto
Hayato Yamamoto
YTYuki Tobisawa
Yuki Tobisawa
FIFumitoshi Irie
Fumitoshi Irie

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FIFumitoshi Irie
Fumitoshi Irie
YTYuki Tobisawa
Yuki Tobisawa
AMAyako Murao
Ayako Murao
HYHayato Yamamoto
Hayato Yamamoto
COChikara Ohyama
Chikara Ohyama
YYYu Yamaguchi
Yu Yamaguchi
The extracellular matrix (ECM) plays an important role in maintaining tissue homeostasis and poses a significant physical barrier to in vivo cell migration. Accordingly, as a means of enhancing tissue invasion, tumor cells use matrix metalloproteinases to degrade ECM proteins. However, the in vivo ECM is comprised not only of proteins but also of a variety of non-protein components. Hyaluronan (HA), one of the most abundant non-protein components of the interstitial ECM, form a gel-like anti-adhesive barrier that is impenetrable to particulate matter and cells. Mechanisms by which tumor cells penetrate the HA barrier have not been addressed. Here we demonstrate that TMEM2, the only known transmembrane hyaluronidase, is the predominant mediator of contact-dependent HA degradation and subsequent integrin-mediated cell-substrate adhesion. We show that a variety of tumor cells are able to eliminate substrate-bound HA in a tightly-localized pattern corresponding to the distribution of focal adhesions (FAs) and stress fibers. This FA-targeted HA degradation is mediated by TMEM2 , which itself is localized at site of FAs. TMEM2 depletion inhibits the ability of tumor cells to attach and migrate in an HA-rich environment. Importantly, TMEM2 directly binds at least two integrins via interaction between extracellular domains. Our findings demonstrate a critical role for TMEM2-mediated HA degradation in the adhesion and migration of cells on HA-rich ECM substrates, and provide novel insight into the early phase of FA formation.

9 November 2017 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
PDF file
TIToshihiro Inubushi
Toshihiro Inubushi
ILIsabelle Lemire
Isabelle Lemire
FIFumitoshi Irie
Fumitoshi Irie
YYYu Yamaguchi
Yu Yamaguchi

6 October 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YTYuki Tobisawa
Yuki Tobisawa
NFNaoki Fujita
Naoki Fujita
HYHayato Yamamoto
Hayato Yamamoto
COChikara Ohyama
Chikara Ohyama
FIFumitoshi Irie
Fumitoshi Irie
YYYu Yamaguchi
Yu Yamaguchi
As a major component of the extracellular matrix, hyaluronan (HA) plays an important role in defining the biochemical and biophysical properties of tissues. In light of the extremely rapid turnover of HA and the impact of this turnover on HA biology, elucidating the molecular mechanisms underlying HA catabolism is key to understanding the in vivo functions of this unique polysaccharide. Here, we show that TMEM2, a recently identified cell surface hyaluronidase, plays an essential role in systemic HA turnover. Employing induced global Tmem2 knockout mice (Tmem2iKO), we determined the effects of Tmem2 ablation not only on the accumulation of HA in bodily fluids and organs, but also on the process of HA degradation in vivo. Within 3 weeks of tamoxifen-induced Tmem2 ablation, Tmem2iKO mice exhibit pronounced accumulation of HA in circulating blood and various organs, reaching levels as high as 40-fold above levels observed in control mice. Experiments using lymphatic and vascular injection of fluorescent HA tracers demonstrate that ongoing HA degradation in the lymphatic system and the liver is significantly impaired in Tmem2iKO mice. We also show that Tmem2 is strongly expressed in endothelial cells in the subcapsular sinus of lymph nodes and in the liver sinusoid, two primary sites implicated in systemic HA turnover. Our results establish TMEM2 as a physiologically relevant hyaluronidase with an essential role in systemic HA catabolism in vivo, acting primarily on the surface of endothelial cells in the lymph nodes and liver.

3 August 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
TIToshihiro Inubushi
Toshihiro Inubushi
SNSatoshi Nozawa
Satoshi Nozawa
KMKazu Matsumoto
Kazu Matsumoto
FIFumitoshi Irie
Fumitoshi Irie
YYYu Yamaguchi
Yu Yamaguchi
Multiple hereditary exostoses (MHE) is characterized by the development of numerous benign bony tumors (osteochondromas). Although it has been well established that MHE is caused by mutations in EXT1 and EXT2 , which encode glycosyltransferase essential for heparan sulfate (HS) biosynthesis, the cellular origin and molecular mechanisms of MHE remain elusive. Here, we show that in Ext1 mutant mice, osteochondromas develop from mesenchymal stem cell–like progenitor cells residing in the perichondrium, and we show that enhanced BMP signaling in these cells is the primary signaling defect that leads to osteochondromagenesis. We demonstrate that progenitor cells in the perichondrium, including those in the groove of Ranvier, highly express HS and that Ext1 ablation targeted to the perichondrium results in the development of osteochondromas. Ext1 -deficient perichondrial progenitor cells show enhanced BMP signaling and increased chondrogenic differentiation both in vitro and in vivo. Consistent with the functional role for enhanced BMP signaling in osteochondromagenesis, administration of the small molecule BMP inhibitor LDN-193189 suppresses osteochondroma formation in two MHE mouse models. Together, our results demonstrate a role for enhanced perichondrial BMP signaling in osteochondromagenesis in mice, and they suggest the possibility of pharmacological treatment of MHE with BMP inhibitors.